CollPlant Biotechnologies (CLGN) Current Assets (2016 - 2026)
CollPlant Biotechnologies' Current Assets was $3.9 million in the quarter ended Jun 30, 2026, down 69.1% from $12.62 million a year earlier.
Powered by 
Analysis
CollPlant Biotechnologies (CLGN) Current Assets (2016 - 2026) Analysis & Trends
As of Dec 31, 2025, Current Assets at CollPlant Biotechnologies came in at $6.75 million, down 48.8% from the prior year.
- Current Assets has now declined for four consecutive years, though with a five-year compound annual growth rate of 3.5% (years ended Dec 2020 to Dec 2025).
- In earlier years, Current Assets was $13.18 million in the year ended Dec 31, 2024 (-53.0%), $28.02 million in the year ended Dec 31, 2023 (-11.5%), $31.66 million in the year ended Dec 31, 2022 (-29.8%) and $45.09 million in the year ended Dec 31, 2021 (+694.3%).
- The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Current Assets since the quarter ended Jun 30, 2019.
- The best year-over-year quarter for Current Assets over five years was the quarter ended Dec 31, 2021 (growth of 694.3%); the worst was the quarter ended Jun 30, 2026 (a decline of 69.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 41.36 Bn |
| 10 | CollPlant Biotechnologies | 4.68 Mn | -17.68 Mn | -456,000.00 | 3.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.90 Mn |
| Mar 31, 2026 | 5.54 Mn |
| Dec 31, 2025 | 6.75 Mn |
| Sep 30, 2025 | 9.62 Mn |
| Jun 30, 2025 | 12.62 Mn |
| Mar 31, 2025 | 12.09 Mn |
| Dec 31, 2024 | 13.18 Mn |
| Sep 30, 2024 | 16.50 Mn |
| Jun 30, 2024 | 20.34 Mn |
| Mar 31, 2024 | 24.48 Mn |
| Dec 31, 2023 | 28.02 Mn |
| Sep 30, 2023 | 31.21 Mn |
| Jun 30, 2023 | 34.86 Mn |
| Mar 31, 2023 | 29.06 Mn |
| Dec 31, 2022 | 31.66 Mn |
| Sep 30, 2022 | 34.46 Mn |
| Jun 30, 2022 | 38.27 Mn |
| Mar 31, 2022 | 42.62 Mn |
| Dec 31, 2021 | 45.09 Mn |
| Sep 30, 2021 | 47.90 Mn |
API Access
CollPlant Biotechnologies Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=CLGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "CLGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=CLGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();